Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$125.35

0.25 (0.20%)

07:43
05/17/18
05/17
07:43
05/17/18
07:43

Leerink confidence in Johnson & Johnson increased by analyst day meeting

Leerink analyst Danielle Antalffy said she came away from Johnson & Johnson's Medical Devices & Consumer analyst day "increasingly confident" that these segments will be able to return to and outpace overall market growth over 2017-22. The analyst, who still sees J&J ultimately returning to and sustaining a "solid mid-single-digit" revenue growth trajectory with upside potential, reiterates her Outperform rating and $160 price target on Johnson & Johnson shares.

  • 21

    May

JNJ Johnson & Johnson
$125.35

0.25 (0.20%)

04/18/18
WELS
04/18/18
NO CHANGE
Target $150
WELS
Outperform
Johnson & Johnson price target lowered to $150 from $160 at Wells Fargo
Wells Fargo analyst Lawrence Biegelsen lowered his price target for Johnson & Johnson to $150 from $160 following quarterly results. The analyst reiterates an Outperform rating on the shares.
04/18/18
LEER
04/18/18
NO CHANGE
Target $160
LEER
Outperform
Johnson & Johnson price target lowered to $160 from $175 at Leerink
Leerink analyst Danielle Antalffy lowered her price target for Johnson & Johnson to $160 from $175 on valuation. The analyst reiterates an Outperform rating on the shares.
04/18/18
DBAB
04/18/18
NO CHANGE
DBAB
Hold
Market overlooking Johnson & Johnson's solid quarter, says Deutsche Bank
Deutsche Bank analyst Kristen Stewart attributes the post-earnings pullback yesterday in shares of Johnson & Johnson to some concerns regarding the sustainability of the pharmaceutical business. She believes, however, that the market is overlooking what she sees as a "solid quarter and improved overall outlook." The analyst views the results favorably and reiterates a Buy rating on the stock. Johnson & Johnson shares currently trade at 16 times the analyst's 2018 earnings estimate, which she notes is a discount to the S&P 500 at 17 times.
04/17/18
PIPR
04/17/18
NO CHANGE
PIPR
J&J commentary positive for pure-play spine names, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien is out discussing derivative calls following Johnson & Johnson's (JNJ) Q1 results. The orthopedic market looked relatively stable, though Hips were notably softer than expected, O'Brien tells investors in a research note. He believes Stryker (SYK) is "clearly taking market share," which he views as an incremental negative for Zimmer Biomet (ZBH). On Spine, some U.S. weakness was expected, but J&J's results could be viewed as concerning given continued weakness since Q3 of 2017, the analyst adds. He thinks the end markets "are ok" and the commentary on J&J losing share benefits pure-play spine names NuVasive (NUVA), Globus Medical (GMED), SeaSpine (SPNE) and K2M Group (KTWO). He believes the pure-plays continue to out-innovate and take share despite the weakness in the overall category. Johnson & Johnson's results also show that the U.S. lens market remains strong and is shifting to 1-Days lenses from weeklies/monthlies, which is a positive for Cooper Companies (COO), O'Brien contends. Lastly, the analyst says the decline in J&J's U.S. diabetes franchise from the Animas exit was faster than expected. This is good for the pump names Insulet (PODD) and Tandem Diabetes (TNDM) and a slight negative for Dexcom (DXCM) as some of those will end up at Medtronic (MDT), O'Brien argues. He continues to believe that both Insulet and Tandem "will gain more than their fair share" of Animas patients.

TODAY'S FREE FLY STORIES

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
05/25/18
05/25
16:20
05/25/18
16:20
Options
Closing CBOE SPX and VIX Index summary for May 25th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMED

OncoMed

$2.81

0.06 (2.18%)

16:19
05/25/18
05/25
16:19
05/25/18
16:19
Syndicate
Breaking Syndicate news story on OncoMed »

OncoMed files $150M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTEM

Molecular Templates

$7.02

0.34 (5.09%)

16:17
05/25/18
05/25
16:17
05/25/18
16:17
Syndicate
Breaking Syndicate news story on Molecular Templates »

Molecular Templates files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
05/25/18
05/25
16:17
05/25/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$272.22

-0.65 (-0.24%)

, USO

United States Oil Fund

$13.68

-0.605 (-4.24%)

16:16
05/25/18
05/25
16:16
05/25/18
16:16
General news
Weekly CFTC Commitment of Traders highlights »

S&P500 net long 2.1K…

SPY

SPDR S&P 500 ETF Trust

$272.22

-0.65 (-0.24%)

USO

United States Oil Fund

$13.68

-0.605 (-4.24%)

GLD

SPDR Gold Trust

$123.21

-0.4 (-0.32%)

FXE

Euro Currency Trust

$111.98

-0.62 (-0.55%)

FXC

CurrencyShares Canadian Dollar Trust

$76.07

-0.37 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
05/25/18
05/25
16:16
05/25/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$102.20

0.1 (0.10%)

16:15
05/25/18
05/25
16:15
05/25/18
16:15
Periodicals
Disney cuts opening weekend sales forecast for 'Solo', Bloomberg says »

Disney cut its domestic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMSA

Fairmount Santrol

$5.51

-0.26 (-4.51%)

16:11
05/25/18
05/25
16:11
05/25/18
16:11
Hot Stocks
Fairmount Santrol, Unimin receive final merger approval »

Fairmount Santrol and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMBL

RumbleON

$4.88

0.16 (3.39%)

16:10
05/25/18
05/25
16:10
05/25/18
16:10
Syndicate
Breaking Syndicate news story on RumbleON »

RumbleON files $20M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAVS

Ageagle Aerial Systems

$2.25

0.04 (1.81%)

16:10
05/25/18
05/25
16:10
05/25/18
16:10
Syndicate
Breaking Syndicate news story on Ageagle Aerial Systems »

Ageagle Aerial Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARCI

Appliance Recycling

$0.82

(0.00%)

16:08
05/25/18
05/25
16:08
05/25/18
16:08
Hot Stocks
Appliance Recycling receives noncompliance notice from NASDAQ »

Appliance Recycling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIT

CIT Group

$51.62

-1.13 (-2.14%)

16:06
05/25/18
05/25
16:06
05/25/18
16:06
Hot Stocks
CIT Group names Marisa Harney chief risk officer »

CIT Group announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRVG

Trivago

$4.81

(0.00%)

16:04
05/25/18
05/25
16:04
05/25/18
16:04
Hot Stocks
Breaking Hot Stocks news story on Trivago »

Par Investment Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGLN

Magellan Health

$90.05

1.1 (1.24%)

15:56
05/25/18
05/25
15:56
05/25/18
15:56
Hot Stocks
Magellan Health boosts stock repurchase authorization to $400M »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

LPI

Laredo Petroleum

$8.60

-0.765 (-8.17%)

15:50
05/25/18
05/25
15:50
05/25/18
15:50
Options
Notable put spread in Laredo Petroleum on a rough week for shares »

Notable put spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$14.57

-0.025 (-0.17%)

15:42
05/25/18
05/25
15:42
05/25/18
15:42
Periodicals
GE lighting business, pursued by multiple suitors, could fetch $1B, FBN says »

Charles Gasparino of Fox…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$37.03

0.15 (0.41%)

15:40
05/25/18
05/25
15:40
05/25/18
15:40
Options
AstraZeneca call buyer opens position 4% above spot »

AstraZeneca call buyer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

HEDJ

WisdomTree Europe Hedged Equity Fund

$66.46

-0.24 (-0.36%)

15:30
05/25/18
05/25
15:30
05/25/18
15:30
Options
Wisdom Tree Europe Hedged Equity Fund attracts put buying »

Wisdom Tree Europe Hedged…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATUS

Altice USA

$18.43

-0.12 (-0.65%)

15:29
05/25/18
05/25
15:29
05/25/18
15:29
Conference/Events
Altice USA management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

CLX

Clorox

$122.59

2.89 (2.41%)

15:25
05/25/18
05/25
15:25
05/25/18
15:25
Options
Clorox call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

QCOM

Qualcomm

$59.67

0.57 (0.96%)

, NXPI

NXP Semiconductors

$116.47

5.03 (4.51%)

15:22
05/25/18
05/25
15:22
05/25/18
15:22
Periodicals
Dealreporter: Qualcomm given ok to resume NXP talks with China, Bloomberg says »

Bloomberg cites…

QCOM

Qualcomm

$59.67

0.57 (0.96%)

NXPI

NXP Semiconductors

$116.47

5.03 (4.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OA

Orbital ATK

$133.80

0.06 (0.04%)

15:20
05/25/18
05/25
15:20
05/25/18
15:20
Hot Stocks
Orbital ATK reports options awarded for two more weather satellites for NOAA »

Orbital ATK announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
05/25/18
05/25
15:17
05/25/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADRNY

Ahold Delhaize

$0.00

(0.00%)

15:16
05/25/18
05/25
15:16
05/25/18
15:16
Conference/Events
Ahold Delhaize management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
05/25/18
05/25
15:16
05/25/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.